Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Assets (2020 - 2022)

Historic Assets for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $686.6 million.

  • Atea Pharmaceuticals' Assets fell 1860.43% to $686.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $686.6 million, marking a year-over-year decrease of 1860.43%. This contributed to the annual value of $772.9 million for FY2021, which is 1050.68% down from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Assets is $686.6 million, which was down 1860.43% from $694.3 million recorded in Q2 2022.
  • Atea Pharmaceuticals' 5-year Assets high stood at $871.5 million for Q2 2021, and its period low was $110.1 million during Q3 2020.
  • Moreover, its 3-year median value for Assets was $772.9 million (2021), whereas its average is $711.2 million.
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 66608.36% in 2021, then plummeted by 2033.23% in 2022.
  • Over the past 3 years, Atea Pharmaceuticals' Assets (Quarter) stood at $863.6 million in 2020, then dropped by 10.51% to $772.9 million in 2021, then dropped by 11.17% to $686.6 million in 2022.
  • Its Assets stands at $686.6 million for Q3 2022, versus $694.3 million for Q2 2022 and $717.2 million for Q1 2022.